Related Experiment Video

Updated: Aug 23, 2026

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75

Baolin Zhang1, Yaqin Zhang, Emily Shacter

  • 1Laboratory of Biochemistry, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892-4555, USA. baolin.zhang@fda.gov

Molecular and Cellular Biology
|July 1, 2004
PubMed

Insights

Active Rac1 (Ras-related C3 botulinum toxin substrate 1) promotes lymphoma cell survival by phosphorylating Bad, inhibiting apoptosis during chemotherapy. This discovery offers new therapeutic targets for cancer treatment.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The small GTPase Rac1 plays a role in cell survival and apoptosis.
  • The precise mechanisms by which Rac1 influences these processes are not fully elucidated.
  • Understanding Rac1's role is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of Rac1 in regulating apoptosis in human lymphoma cells.
  • To identify the specific molecular targets and pathways involved in Rac1-mediated cell survival.
  • To explore potential therapeutic strategies for enhancing chemotherapy efficacy.

Main Methods:

  • Utilized constitutively active Rac1 in human lymphoma cells.
  • Assessed Bad phosphorylation at serine-75 in vitro and in vivo.
  • Employed a cell-permeable peptide inhibitor to block Bad phosphorylation.
  • Investigated the involvement of protein kinase A (PKA) and Akt in the pathway.

Main Results:

  • Constitutively active Rac1 stimulated Bad phosphorylation at serine-75, suppressing drug-induced apoptosis.
  • Inhibition of Rac1-induced Bad phosphorylation sensitized cells to apoptosis.
  • Endogenous protein kinase A was identified as the primary catalyst for Bad phosphorylation upon Rac1 activation.
  • Akt was found not to be involved in this specific pathway.

Conclusions:

  • Active Rac1 promotes lymphoma cell survival by phosphorylating Bad, thereby inhibiting apoptosis.
  • This mechanism is significant in the context of cancer chemotherapy.
  • Targeting the Rac1-Bad phosphorylation pathway could enhance the effectiveness of cancer treatments.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...